ECRI Institute today identified surgical stapler misuse as the leading health technology safety concern. In March, the Food and Drug Administration issued recommendations for health care providers to reduce the risk of adverse events associated with surgical staplers and staples for internal use. ECRI said other leading health technology risks include: point-of-care ultrasound; sterile processing in medical and dental offices; hemodialysis with central venous catheters; unproven surgical robotic procedures; alarm, alert and notification overload; cybersecurity in the connected home health care environment; missing patient implant data for magnetic resonance imaging; medication dose timing discrepancies in electronic health records; and loose medical device components. 

Related News Articles

In this AHA Stat blog, Robyn Begley, AHA senior vice president and CEO of the American Organization for Nursing Leadership, discusses how hiring and empowering…
The AHA and six other organizations today submitted comments to the Drug Enforcement Administration on its proposed rule regarding controlled substances quotas.
Insights and Analysis
The University Medical Center of El Paso treated 15 victims after a shooting at a nearby store in August. Staff credit training for their quick and calm…
The Food and Drug Administration last week authorized marketing of a rapid diagnostic test to detect Ebola virus antigens in human blood from certain living…
The Food and Drug Administration Oct. 11 approved a new tablet for the acute treatment of migraine headache pain.
Chairperson's File
“Get vaccinated” is a message everyone should hear, and hospitals and health systems are the ideal partners to spread it.